New MAA: First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma

xlomafota13 shared this article with you from Inoreader New MAA: First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma Via Association française pour l'étude du cancer Bull Cancer. 2021 Nov 27:S0007-4551(21)00437-9. doi: 10.1016/j.bulcan.2021.09.013. Online ahead of print. NO ABSTRACT PMID:34848048 | DOI:10.1016/j.bulcan.2021.09.013 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.